Liraglutide, a weight-loss drug, may slow cognitive decline in Alzheimer's patients by reducing brain volume loss, potentially altering the course of the disease.
The trial on 204 UK patients showed liraglutide reduced brain shrinkage in memory and decision-making centers by nearly 50%, with 18% slower cognitive decline after a year compared to the placebo.
Collection
[
|
...
]